Search Results 141-150 of 16740 for Lou Gehrig's disease

  1. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR ( ...

  2. Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients with ALS - Mayo Clinic

    ... ALS. Print details. Share; Facebook · Twitter. Overview ... ALS . MSC-NTF ... History of autoimmune disease, myelodysplastic or myeloproliferative disorder ...

  3. A Study to Understand the Connections Between Brain Functioning and Speech in Patients with ALS - Mayo Clinic

    Clinical Trials · A Study to Understand the Connections Between Brain Functioning and Speech in Patients with ALS · More about research at Mayo Clinic · Mayo ...

  4. Rimabotulinumtoxinb (intramuscular route) - Mayo Clinic

    Other Medical Problems · Amyotrophic lateral sclerosis (Lou Gehrig's disease) or · Lambert-Eaton syndrome (nerve-muscle disorder) or · Motor neuropathy (muscle or ...

  5. Daxibotulinumtoxina-lanm (intramuscular route) - Mayo Clinic

    Amyotrophic lateral sclerosis (Lou Gehrig's disease) or; Cornea or eye problems or; Heart or blood vessel disease or · Breathing problems (eg, asthma, emphysema) ...

  6. Mayo Clinic Research in Florida

    ... disease, Alzheimer's disease and amyotrophic lateral sclerosis (Lou Gehrig's disease), as well as breast and ovarian cancer. All researchers in Florida · Core ...

  7. Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS - Mayo Clinic

    ... (ALS), based on the time from the randomization date in Study MT-1186-A02 to at least a 12-point decrease in Revised ALS ... disease, and previous treatments or ...

  8. A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis - Mayo Clinic

    ... (ALS). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  9. Prabotulinumtoxina-xvfs (intramuscular route) - Mayo Clinic

    Amyotrophic lateral sclerosis (Lou Gehrig's disease) or; Cornea or eye problems or; Heart or blood vessel disease or; Lambert-Eaton syndrome (nerve-muscle ...

  10. Abobotulinumtoxina (intramuscular route) - Mayo Clinic

    Other Medical Problems · Amyotrophic lateral sclerosis (Lou Gehrig's disease) or · Dermatochalasis (a skin problem) or · Lambert-Eaton syndrome (nerve-muscle ...